ANIPANI Pharmaceuticals, Inc.

ANIP Stock Price, Valuation & Chart | ANI Pharmaceuticals, Inc.

$73.060+1.14 (+1.59%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic ANIP intrinsic value ANIP calculated fair value vs price

Overview Financials Dividends Ratios

ANIP Historical price chart

ANIP Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.66B

PE Ratio8.89

EPS8.22

Trading Volume287.59K

Today's High/Low73.44/72.47

Dividend Yield0.00

52 Week High/Low99.5/70.15

Shares Outstanding22.73M

ANIP Financial Statement

ANIP Analyst ratings

ANIP Analysis & performance metrics

ANIP Company profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.…

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals;…

ANIP Management team

Name

Position

Stephen P. CareyCFO

Senior Vice President of Finance & Chief Financial Officer

Meredith W. Cook J.D.

Senior Vice President, General Counsel & Corporate Secretary

Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Krista L. Davis

Senior Vice President & Chief Human Resources Officer

Mary Pao M.D., Ph.D.

Chief Medical Officer

Ori Gutwerg

Senior Vice President of Generics

Muthusamy Shanmugam MS R.Ph.COO

Head of R&D, Chief Operating Officer of New Jersey Operations & Director

Christopher K. Mutz

Senior Vice President & Head of Rare Disease

Name

Position

Stephen P. CareyCFO

Senior Vice President of Finance & Chief Financial Officer

Meredith W. Cook J.D.

Senior Vice President, General Counsel & Corporate Secretary

Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Krista L. Davis

Senior Vice President & Chief Human Resources Officer

Mary Pao M.D., Ph.D.

Chief Medical Officer

Ori Gutwerg

Senior Vice President of Generics

Muthusamy Shanmugam MS R.Ph.COO

Head of R&D, Chief Operating Officer of New Jersey Operations & Director

Christopher K. Mutz

Senior Vice President & Head of Rare Disease

Management Team

Stephen P. CareyCFO

Senior Vice President of Finance & Chief Financial Officer

Meredith W. Cook J.D.

Senior Vice President, General Counsel & Corporate Secretary

Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Krista L. Davis

Senior Vice President & Chief Human Resources Officer

Mary Pao M.D., Ph.D.

Chief Medical Officer

Ori Gutwerg

Senior Vice President of Generics

Muthusamy Shanmugam MS R.Ph.COO

Head of R&D, Chief Operating Officer of New Jersey Operations & Director

Christopher K. Mutz

Senior Vice President & Head of Rare Disease

Management

Stephen P. CareyCFO

Senior Vice President of Finance & Chief Financial Officer

Meredith W. Cook J.D.

Senior Vice President, General Counsel & Corporate Secretary

Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Krista L. Davis

Senior Vice President & Chief Human Resources Officer

Mary Pao M.D., Ph.D.

Chief Medical Officer

Ori Gutwerg

Senior Vice President of Generics

Muthusamy Shanmugam MS R.Ph.COO

Head of R&D, Chief Operating Officer of New Jersey Operations & Director

Christopher K. Mutz

Senior Vice President & Head of Rare Disease

Total 8 executives

ANIP Frequently asked questions

What is ANI Pharmaceuticals, Inc. (ANIP) Stock Price?

Current stock price of ANI Pharmaceuticals, Inc. (ANIP) stock is $73.060. The stock price is +1.59% higher in the session. The intraday range can be seen from this page. Volume of ANI Pharmaceuticals, Inc. (ANIP) stock is 287.59K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the ANI Pharmaceuticals, Inc. (ANIP) stock price going up or down today?

The stock price of ANI Pharmaceuticals, Inc. (ANIP) can change with earnings, company news, and overall market sentiment. ANI Pharmaceuticals, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the ANI Pharmaceuticals, Inc. stock expensive at its current price?

Whether ANI Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANIP on this page is 8.89. EPS on this page is 8.22. Compare those figures with peers and growth expectations before deciding if the current ANI Pharmaceuticals, Inc. price is justified.

How has the stock price of ANI Pharmaceuticals, Inc. (ANIP) performed historically?

Historical performance for ANI Pharmaceuticals, Inc. (ANIP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANIP reacted to past earnings and market events.

Should I buy ANI Pharmaceuticals, Inc. (ANIP) stock, at this price?

Buying ANI Pharmaceuticals, Inc. (ANIP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.